MB Geštalto terapijos namai Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 3,520 |
| - |
| 3,520 |
| 3,520 |
| - |
| 100.00 |
| 100.00 |
| 3,521 |
| 0 |
| 0 |
| 3,521 |
| 1.00 |
| 0.00 |
| - |
| - |
| 100.00 |
| 3,520 |
| 2024 |
|---|
| 15,740 |
| - |
| 985 |
| 936 |
| - |
| 100.00 |
| 5.95 |
| 937 |
| 240 |
| 0 |
| 1,177 |
| 0.06 |
| 0.26 |
| - |
| - |
| 6.26 |
| 985 |
| 2025 |
|---|
| 31,320 |
| - |
| 2,061 |
| 1,937 |
| - |
| 100.00 |
| 6.18 |
| 2,873 |
| 369 |
| 0 |
| 3,242 |
| 0.09 |
| 0.13 |
| - |
| - |
| 6.58 |
| 2,061 |
| 2025 |
|---|
| 31,320 |
| - |
| 2,061 |
| 1,937 |
| - |
| 100.00 |
| 6.18 |
| 2,873 |
| 369 |
| 0 |
| 3,242 |
| 0.09 |
| 0.13 |
| - |
| - |
| 6.58 |
| 2,061 |
Turnover (€)
2025
Turnover (€)
31,320 €99 % *
Sales per employee (€)
-Profit before tax (€)
2,061 €109 % *
Net Profit (€)
1,937 €107 % *
Profit per employee (€)
-Total profitability (%)
100.00 %0.00 % *
Net profitability (%)
6.18 %3.87 % *
Equity (€)
2,873 €207 % *
Amounts Payable And Liabilities (€)
369 €54 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
3,242 €175 % *
Working capital requirement
0.09 50.00 % *
Debt-to-equity ratio
0.13 -50.00 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
6.58 %5.11 % *
EBIT (€)
2,061 €109 % *
